Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus
- PMID: 20535788
- DOI: 10.1002/acr.20133
Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus
Abstract
Objective: Hydroxychloroquine (HCQ) retinopathy is of concern because of the potential seriousness of visual loss and the medicolegal consequences of failure to detect toxicity. However, there have been limited demographic data on which to base recommendations for screening. We have studied the largest unselected series of patients to date to evaluate the risk of toxicity and the relevance of purported risk factors.
Methods: We studied 3,995 patients with rheumatoid arthritis or systemic lupus erythematosus who had used HCQ, including 1,538 current users. We screened for self-reported toxicity, and followed up on positive cases with detailed interviews and specialist confirmation. We categorized cases as "definite or probable" if there was bull's eye maculopathy or visual field loss.
Results: Of the lifetime users of HCQ, 6.5% discontinued therapy because of an eye problem, including 1.8% who reported HCQ retinal problems. However, definite or probable toxicity was documented in only 0.65% (95% confidence interval 0.31-0.93). The risk of toxicity was low in the initial 7 years of exposure, and was approximately 5 times greater after 7 years of usage (or 1,000 gm total exposure). Toxicity was unrelated to age, weight, or daily dosage. Eye examinations were obtained annually by 50.5% and every 6 months by 40.4% of patients.
Conclusion: HCQ toxicity remains uncommon, but increases markedly with the duration of therapy and exceeds 1% after 5-7 years. Toxicity was unassociated with age, daily dosage, or weight. These findings will aid the reformulation of screening guidelines.
Similar articles
-
Discontinuation of antimalarial drugs in systemic lupus erythematosus.J Rheumatol. 1999 Apr;26(4):808-15. J Rheumatol. 1999. PMID: 10229401
-
The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.Ophthalmology. 2003 Jul;110(7):1321-6. doi: 10.1016/S0161-6420(03)00409-3. Ophthalmology. 2003. PMID: 12867385
-
Missing the bull's eye.Surv Ophthalmol. 2007 Jul-Aug;52(4):440-2. doi: 10.1016/j.survophthal.2007.04.001. Surv Ophthalmol. 2007. PMID: 17574068
-
Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.J Am Optom Assoc. 1993 Nov;64(11):787-97. J Am Optom Assoc. 1993. PMID: 8120333 Review.
-
Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.Expert Opin Drug Saf. 2011 Sep;10(5):705-14. doi: 10.1517/14740338.2011.566555. Epub 2011 Mar 22. Expert Opin Drug Saf. 2011. PMID: 21417950 Review.
Cited by
-
Spectral domain optical coherence tomography-based prevalence of hydroxychloroquine maculopathy in Indian patients on hydroxychloroquine therapy: A utopia of underdiagnosis.Med J Armed Forces India. 2020 Oct;76(4):395-401. doi: 10.1016/j.mjafi.2020.04.012. Epub 2020 May 21. Med J Armed Forces India. 2020. PMID: 32836708 Free PMC article.
-
A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.Clin Rev Allergy Immunol. 2015 Dec;49(3):317-26. doi: 10.1007/s12016-015-8469-8. Clin Rev Allergy Immunol. 2015. PMID: 25672591 Review.
-
Macular toxicity after short-term hydroxychloroquine therapy.Indian J Ophthalmol. 2019 Feb;67(2):289-292. doi: 10.4103/ijo.IJO_732_18. Indian J Ophthalmol. 2019. PMID: 30672499 Free PMC article.
-
The role of antimalarial agents in the treatment of SLE and lupus nephritis.Nat Rev Nephrol. 2011 Oct 18;7(12):718-29. doi: 10.1038/nrneph.2011.150. Nat Rev Nephrol. 2011. PMID: 22009248 Review.
-
Hydroxychloroquine in COVID-19 Patients: Pros and Cons.Front Pharmacol. 2020 Nov 19;11:597985. doi: 10.3389/fphar.2020.597985. eCollection 2020. Front Pharmacol. 2020. PMID: 33364965 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical